Eight drugs expected to reach blockbuster status by 2021, says report

12-04-2017

The 2017 “Drugs to Watch” report predicts that eight new drugs will enter the market this year and each achieve $1 billion in annual sales by 2021.


Drugs to watch, report, blockbuster, Clarivate Analytics, Regeneron, Sanofi, AstraZeneca, Novo Nordisk, Lilly, Incyte, Merck, Novartis, Tesaro, drugs, FDA

LSIPR